Status:
TERMINATED
Estimating Blood Loss Using TritonTM in Vaginal Deliveries: A Validation Trial
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Conditions:
Post Partum Hemorrhage
Blood Loss
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This study will be a prospective cohort study. Patients who meet criteria for inclusion in the study will be approached for participation at same day of admission. Written informed consent will be obt...
Detailed Description
Postpartum hemorrhage (PPH) is the leading cause of maternal mortality in low-income countries and the primary cause of nearly one quarter of all maternal deaths globally (1). An estimated blood loss ...
Eligibility Criteria
Inclusion
- Criteria for inclusion of subjects:
- Pregnant women between the ages of 18-50. Plan of care is vaginal delivery.
- Criteria for exclusion of subjects:
- Incarcerated patients. Patient unwilling or unable to provide consent. Intrauterine fetal demise (no fetal heart beat identified and documented by two physicians).
- Placenta previa or other known placental anomalies. Any contraindications to vaginal delivery. Enrolled in another trial that may affect outcome.
Exclusion
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04277962
Start Date
May 1 2020
End Date
June 30 2021
Last Update
June 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UTMB Galveston
Galveston, Texas, United States, 77555